Computational characterization of Plasmodium falciparum proteomic data for screening of potential vaccine candidates.

Advancement in the field of proteomics and bioinformatics offers tremendous opportunities for the development of novel epitope-based effective vaccine against human malaria. In this study, we have characterized 25 antigens as a vaccine candidate and screened the potential T-lymphocyte epitopes presented by human leukocyte antigen (HLA)-A, -B, and -DR molecules based on the proteomic data of Plasmodium falciparum. Of the 25 proteins, 22 were predicted as probable antigens and two were predicted as adhesions. In addition, seven proteins were predicted to contain signal peptide for secretary pathway and six proteins were found similar to the human and mouse reference proteins, whereas none of the proteins were predicted as allergen. A total of 14,841 peptides were predicted as epitope, presented by HLA class I and II supertypes that covered a broad human population (approximately 95%). Our results suggest that HLA-based multistage and multiepitope malaria vaccine would likely be needed to induce broader CD8(+) as well as CD4(+) T-cell responses. The predicted epitopes may be served as a useful diagnostic reagent for evaluating T-cell responses in the context of natural infection and/or vaccine trials.

[1]  A Sette,et al.  The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. , 2001, Biologicals : journal of the International Association of Biological Standardization.

[2]  A Sette,et al.  Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. , 1999, Journal of immunology.

[3]  A. Hill,et al.  The immunology of malaria infection. , 2000, Current opinion in immunology.

[4]  J Alexander,et al.  Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. , 2002, Tissue antigens.

[5]  Srinivasan Ramachandran,et al.  MAAP: Malarial adhesins and adhesin‐like proteins predictor , 2008, Proteins.

[6]  S. Brunak,et al.  Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. , 2000, Journal of molecular biology.

[7]  Andrey V Kajava,et al.  Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens. , 2007, Endocrine, metabolic & immune disorders drug targets.

[8]  R W Chesnut,et al.  Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. , 1997, The Journal of clinical investigation.

[9]  Adrian J F Luty,et al.  Protection against a malaria challenge by sporozoite inoculation. , 2009, The New England journal of medicine.

[10]  B. Walker,et al.  Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. , 1997, Journal of immunology.

[11]  Ellis L Reinherz,et al.  Definition of MHC Supertypes Through Clustering of MHC Peptide Binding Repertoires , 2004, ICARIS.

[12]  D. Flower,et al.  Bioinformatic Approach for Identifying Parasite and Fungal Candidate Subunit Vaccines , 2008 .

[13]  J R Yates,et al.  Utilization of genomic sequence information to develop malaria vaccines , 2003, Journal of Experimental Biology.

[14]  O. Lund,et al.  Definition of supertypes for HLA molecules using clustering of specificity matrices , 2004, Immunogenetics.

[15]  John Sidney,et al.  Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[17]  Heng Wang,et al.  Construction and immunogenicity prediction of Plasmodiumfalciparum CTL epitope minigene vaccine , 2001, Science in China Series C: Life Sciences.

[18]  S. Markovic,et al.  Challenges in the development of effective peptide vaccines for cancer. , 2002, Mayo Clinic proceedings.

[19]  Feng Chen,et al.  OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups , 2005, Nucleic Acids Res..

[20]  Patricia De la Vega,et al.  Development, Characterization and Immunogenicity of a Multi-Stage, Multivalent Plasmodium falciparum Vaccine Antigen (FALVAC-1A) Expressed in Escherichia coli , 2006, Human vaccines.

[21]  Morten Nielsen,et al.  Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction , 2007, BMC Bioinformatics.

[22]  C. Parra-López,et al.  A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite Challenge , 2006, Infection and Immunity.

[23]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[24]  Irini A. Doytchinova,et al.  In Silico Identification of Supertypes for Class II MHCs1 , 2005, The Journal of Immunology.

[25]  Gajendra P. S. Raghava,et al.  AlgPred: prediction of allergenic proteins and mapping of IgE epitopes , 2006, Nucleic Acids Res..

[26]  T. Tan,et al.  A systematic bioinformatics approach for selection of epitope-based vaccine targets. , 2006, Cellular immunology.

[27]  T. Richie,et al.  Progress and challenges for malaria vaccines , 2002, Nature.

[28]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[29]  John Sidney,et al.  HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles1 2 , 2000, The Journal of Immunology.

[30]  O. Lund,et al.  An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.

[31]  Jonathan E. Allen,et al.  Genome sequence of the human malaria parasite Plasmodium falciparum , 2002, Nature.

[32]  A. Hill,et al.  A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Patricia De la Vega,et al.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.

[34]  A Sette,et al.  Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. , 2001, Human immunology.

[35]  David L. Tabb,et al.  A proteomic view of the Plasmodium falciparum life cycle , 2002, Nature.

[36]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[37]  Irini A. Doytchinova,et al.  BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .

[38]  E. Celis,et al.  Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen. , 2001, Cancer research.

[39]  A. Vitiello,et al.  The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.

[40]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[41]  Bhartendu Nath Mishra,et al.  Prediction of MHC binding peptide using Gibbs motif sampler, weight matrix and artificial neural network , 2008, Bioinformation.

[42]  Julia V Ponomarenko,et al.  EpitopeViewer: a Java application for the visualization and analysis of immune epitopes in the Immune Epitope Database and Analysis Resource (IEDB) , 2007, Immunome research.

[43]  Vladimir Brusic,et al.  MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides , 2005, Nucleic Acids Res..